These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 33674759)

  • 1. COVID-19 vaccines: modes of immune activation and future challenges.
    Teijaro JR; Farber DL
    Nat Rev Immunol; 2021 Apr; 21(4):195-197. PubMed ID: 33674759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixing vaccines may boost immune responses.
    Vogel G
    Science; 2021 Jun; 372(6547):1138. PubMed ID: 34112673
    [No Abstract]   [Full Text] [Related]  

  • 3. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
    Donahue RN; Marté JL; Goswami M; Toney NJ; Tsai YT; Gulley JL; Schlom J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.
    Groß R; Zanoni M; Seidel A; Conzelmann C; Gilg A; Krnavek D; Erdemci-Evin S; Mayer B; Hoffmann M; Pöhlmann S; Liu W; Hahn BH; Beil A; Kroschel J; Jahrsdörfer B; Schrezenmeier H; Kirchhoff F; Münch J; Müller JA
    EBioMedicine; 2022 Jan; 75():103761. PubMed ID: 34929493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.
    Wang Y
    EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128
    [No Abstract]   [Full Text] [Related]  

  • 6. Covid-19 vaccines: delivering protective immunity.
    Sewell HF; Agius RM; Kendrick D; Stewart M
    BMJ; 2020 Dec; 371():m4838. PubMed ID: 33334862
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
    Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S
    Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination--new facts from basic research].
    Dalpke AH
    MMW Fortschr Med; 2010 Jul; 152 Suppl 2():42-6. PubMed ID: 21591318
    [No Abstract]   [Full Text] [Related]  

  • 9. Newborns' passive humoral SARS-CoV-2 immunity following heterologous vaccination of the mother during pregnancy.
    Gloeckner S; Hornung F; Heimann Y; Schleussner E; Deinhardt-Emmer S; Loeffler B; Zoellkau J
    Am J Obstet Gynecol; 2022 Feb; 226(2):261-262. PubMed ID: 34648744
    [No Abstract]   [Full Text] [Related]  

  • 10. Fast Development of High-Quality Vaccines in a Pandemic.
    Pischel L; Yildirim I; Omer SB
    Chest; 2021 Jul; 160(1):e1-e3. PubMed ID: 33848535
    [No Abstract]   [Full Text] [Related]  

  • 11. T Cell Memory: Understanding COVID-19.
    Jarjour NN; Masopust D; Jameson SC
    Immunity; 2021 Jan; 54(1):14-18. PubMed ID: 33406391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What the Omicron wave is revealing about human immunity.
    Willyard C
    Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC).
    Gauci ML; Coutzac C; Houot R; Marabelle A; Lebbé C;
    Eur J Cancer; 2021 May; 148():121-123. PubMed ID: 33743480
    [No Abstract]   [Full Text] [Related]  

  • 14. Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
    Shen CF; Yen CL; Fu YC; Cheng CM; Shen TC; Chang PD; Cheng KH; Liu CC; Chang YT; Chen PL; Ko WC; Shieh CC
    Front Immunol; 2022; 13():807454. PubMed ID: 35145520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
    Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
    Reynaud CA; Weill JC; Chappert P; Mahévas M
    Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
    [No Abstract]   [Full Text] [Related]  

  • 17. mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients.
    Azzolini E; Pozzi C; Germagnoli L; Oresta B; Carriglio N; Calleri M; Selmi C; De Santis M; Finazzi S; Carlo-Stella C; Bertuzzi A; Motta F; Ceribelli A; Mantovani A; Bonelli F; Rescigno M
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35169017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission.
    Horiuchi S; Oishi K; Carrau L; Frere J; Møller R; Panis M; tenOever BR
    Sci Immunol; 2021 Dec; 6(66):eabm3131. PubMed ID: 34699266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How 'killer' T cells could boost COVID immunity in face of new variants.
    Ledford H
    Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217
    [No Abstract]   [Full Text] [Related]  

  • 20. T Cells: Warriors of SARS-CoV-2 Infection.
    de Candia P; Prattichizzo F; Garavelli S; Matarese G
    Trends Immunol; 2021 Jan; 42(1):18-30. PubMed ID: 33277181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.